Evidence map›Paper›PMID 9573217›Full record

ReviewJournal of virology1998

Does nitric oxide play a critical role in viral infections?

C S Reiss, T Komatsu

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04337918 (Multi-Center, Randomized, Controlled, Phase II Clinical Efficacy Study Evaluating Nitric Oxide Releasing Solution Treatment for the Prevention and Treatment of COVID-19 in Healthcare Workers and Individuals at Risk of Infection), which is not on this map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04337918 phase2completednot on this mapstarted 2020, after this paper: background citation

Multi-Center, Randomized, Controlled, Phase II Clinical Efficacy Study Evaluating Nitric Oxide Releasing Solution Treatment for the Prevention and Treatment of COVID-19 in Healthcare Workers and Individuals at Risk of Infection

TypeinterventionalSponsorSanotize Research and Development corp.Ran2020 to 2021Enrolled143ConditionsCorona Virus InfectionArmsNORS (Nitric Oxide Releasing Solution)
3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 270 citations in OpenAlex.

  1. Trial
  2. Article
  3. Turkey Hemorrhagic Enteritis (THE): A Short Overview.Pathogens (Basel, Switzerland) · 2024
    Review
  4. Article
  5. Strategies of Pathogens to Escape from NO-Based Host Defense.Antioxidants (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

C S ReissDepartment of Biology, Center for Neural Science and Kaplan Comprehensive Cancer Center, New York University, New York, New York 10003-6688, USA. Carol.Reiss@nyu.edu
T Komatsu
New York University · US

Funding

PHS HHS 3536
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsHumansImmunityNitric OxideViral VaccinesVirus DiseasesNitric OxideViral Vaccines

Identifiers

PMID9573217
PMCPMC109964
OpenAlexW2122299206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.